Zimbabwe has declined a significant US health deal valued at 367 million US dollars (272 million pounds) spanning five years over the United States' request for confidential biological samples.
This rejection was revealed after a government memo dated December was disclosed, revealing that President Emmerson Mnangagwa felt the agreement was "lopsided".
An official representative later clarified that the United States was demanding access to health data for scientific study and commercial purposes but refused to guarantee the resulting advantages from future treatments.
"We must now begin the difficult and regrettable task of scaling back our support in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy said the United States had donated more than $1.9bn for health programmes to Zimbabwe during the past twenty years.
A medical body in Zimbabwe has appealed for more talks to secure a agreement suitable to all parties so the nation's vital HIV programme can proceed.
Wider Implications
This development follows a similar case in Kenya, where a court halted a related deal with the US following legal challenges were raised about the safety of citizens' health data.
After returning to the presidency recently, US President Donald Trump has reduced overseas assistance and closed the key foreign aid agency.
USAID had administered assistance for the American government, but Trump claimed its expenditure was "wasteful" and his government was seeking government-to-government deals to boost openness and responsibility.
Based on statements, Sixteen African countries have to date agreed to similar agreements, representing over $18.3bn in committed funds.
Specifics of the Rejected Agreement
This assistance for Zimbabwe was intended to gone towards "tackling HIV/Aids, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"It is our view this cooperation would have delivered extraordinary advantages for Zimbabwean communities, especially the 1.2 million men, women and children currently on HIV treatment through US-supported programmes," the Ambassador added.
However, government spokesperson Nick Mangwana said the arrangement was "unequal".
"The proposal required Zimbabwe to share its biological resources and data over an extended period, without any equivalent assurance of benefiting from any scientific breakthroughs – like vaccines, diagnostics, or treatments – that could be developed from that shared data," his statement read.
"In essence, our country would provide the raw materials for medical research with no assurance that the final treatments would be available to our people should a future pandemic arise."
Sovereignty and Global Health
He also said that the US's withdrawal from the World Health Organization (WHO) and its pursuit of one-on-one health agreements were undermining structures already set up through the international health agency.
Mangwana gave as an example its Pandemic Benefit-Sharing scheme designed to deal with future global health emergencies.
"This framework is intended to ensure that when a nation contributes its information, the benefits – such as vaccines and treatments – are shared equitably, not monopolised exclusively by those with the capability to create them."
Zimbabwe's reservations regarding the US deal "must not be interpreted as anti-American sentiment," he added.
"We are open to further discussions with our American counterparts on how future co-operation could be designed in a way that honours the sovereignty and dignity of each country."
Medical Community Reaction
A leading public health body expressed it recognised the official position, but recommended that negotiations should continue since much of the country's HIV programmes relied on international support.
"If technical issues arise, including those relating to data governance or implementation frameworks, these can often be resolved through detailed discussion and mutually agreed protections," the group added.
This impasse highlights the continuing challenges between receiving much-needed foreign assistance and protecting a country's data in an ever more interconnected world.